Interventional Cardiology Market Size, Share & COVID19 Impact Analysis | Global | 2023-2029 | MedSuite | Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more

  • Year: 2023
  • Scope: 10 Years
  • Region: Global
  • Pages: 577
  • Type: MedSuite

Product Description

Overall, the global interventional cardiology market was valued at $11 billion in 2022. This is expected to increase over the forecast period at a CAGR of 2.4% to reach $13 billion.

The full report suite on the global market for interventional cardiology includes the coronary stent, coronary balloon catheter, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, atherectomy and intravascular lithotripsy (IVL) device, coronary introducer sheath, coronary vascular closure device (VCD), diagnostic catheter and guidewire, optical coherence tomography (OCT) catheter and intravascular ultrasound (IVUS) catheter markets.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Interventional Cardiology Procedure Volumes
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Global Interventional Cardiology market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Global Interventional Cardiology market
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Interventional Cardiology Market Insights

Access to healthcare and overall hospital infrastructure in developing countries within Latin America and Asia-Pacific countries such as China and India have been increasing over the last decade. This has allowed for more of the global population to get interventional procedures completed as well as the expansion of the device market. Prices are expected to continue to decline over the forecast period, driven by the trend of consolidation in the market and bundling. Due to the number of competitors in the market, they often bundle together devices at a lower price in order to increase overall sales.

Interventional Cardiology Market Overview

Adoption of intravascular imaging technologies is not yet equal across the globe. North America and Asia Pacific continue to have the highest usage rate of the devices, while the rest of the globe maintain a slow but growing use of the technology.

Global Interventional Cardiology Market Share Insight

In 2022, the global interventional cardiology market share was controlled by three key competitors – Boston Scientific, Abbott, and Medtronic.

Top Global Interventional Cardiology Device Market

Boston Scientific was the leader of several segments, including coronary stents, balloon catheters and embolic protection devices. Boston Scientific’s wide range of devices and complementary products for interventional cardiology, combined with its international sales team, has allowed it to maintain its dominant position

Abbott led the interventional coronary guidewire and OCT catheter markets in Western Europe. The Xience™ drug-eluting stent is a popular CTO-indicated line of coronary stents in terms of units sold.

Medtronic has a presence in the coronary stent, coronary balloon catheter, interventional coronary catheter, diagnostic catheter and guidewire, Interventional Coronary catheter, Guidewire Market, Embolic Protection Device Market and Coronary Introducer Sheath Market. Medtronic performed in the interventional coronary catheter market, where it offered the Launcher®, Sherpa NX™ Active, Sherpa NX™ Balanced and Telescope™ product lines under its portfolio.

Report Geographic Coverage

Throughout this research series, iData Research has covered several regions in great detail. The regions covered are:

  • North America (United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa( South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Detailed Market Segmentation

While this MedSuite report contains all the Global Interventional Cardiology Devices market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

  • Coronary Stent Market – MedCore 
  • Coronary Balloon Catheter Market – MedCore
  • Interventional Coronary Catheter Market – MedCore 
  • Interventional Coronary Guidewire Market – MedCore
  • Coronary Embolic Protection Device Market – MedCore 
  • Coronary Atherectomy & Intravascular Lithotripsy (IVL) Device Market – MedCore 
  • Coronary Introducer Sheath Market – MedCore
  • Coronary Vascular Closure Device (VCD)  Market – MedCore
  • Diagnostic Coronary Catheter & Guidewire Market – MedCore
  • Intravascular Ultrasound (IVUS) Market – MedCore
  • Coronary Optical Coherency Tomography Catheter Market – MedCore

RESEARCH SCOPE SUMMARY

Report AttributeDetails
RegionsNorth America (United States and Canada)

Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)

Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)

Central & Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)

Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)

Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Base Year2022
Forecast2023-2029
Historical Data2019-2022
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

  • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Table of Contents:
TABLE of CONTENTS
TABLE of CONTENTSi
List of Figuresxii
List of Chartsxxviii
executive summary1
Global Interventional Cardiology Device Market Overview1
Competitive Analysis3
Market Trends7
Market Developments9
Procedures Included11
Markets Included12
Regions Included13
Version History15
research methodology16
Step 1: Project Initiation & Team Selection16
Step 2: Prepare Data Systems and Perform Secondary Research19
Step 3: Preparation for Interviews & Questionnaire Design21
Step 4: Performing Primary Research22
Step 5: Research Analysis: Establishing Baseline Estimates24
Step 6: Market Forecast and Analysis25
Step 7: Identify Strategic Opportunities27
Step 8: Final Review and Market Release28
Step 9: Customer Feedback and Market Monitoring29
impact of covid-19 on THE global Interventional cardiology Market30
2.1 Introduction30
2.2 Regional Profiles32
2.3 Analysis By Market Segment34
2.3.1 Worst Case Scenario34
2.3.2 Base Case Scenario36
2.3.3 Best Case Scenario38
Disease Overview41
3.1 Basic Anatomy41
3.2 Disease Treatment and Diagnostic43
3.2.1 General Diagnostics43
3.2.2 Coronary Artery Disease43
3.2.3 Myocardial Infarction44
3.2.4 Angina Pectoris45
3.3 Patient Demographics46
Product Assessment48
4.1 Introduction48
4.2 Product Portfolios49
4.2.1 Coronary Stent Market49
4.2.2 Coronary Balloon Catheter Market51
4.2.3 Interventional Coronary Catheter Market53
4.2.4 Interventional Coronary Guidewire Market55
4.2.5 Coronary Embolic Protection Device Market57
4.2.5.1 Saphenous Vein Grafts57
4.2.5.2 Protection Mechanism57
4.2.5.2.1 Filter Basket57
4.2.5.2.2 Distal Balloon Occlusion58
4.2.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market59
4.2.7 Introducer Sheath Market61
4.2.8 Coronary Vascular Closure Device Market64
4.2.9 Diagnostic Coronary Catheter & Guidewire Market66
4.2.10 Coronary Intravascular Ultrasound Market68
4.2.11 Coronary Optical Coherence Tomography Market70
4.3 Regulatory Issues and Recalls72
4.3.1 Coronary Stent Market FDA Recalls72
4.3.2 Coronary Balloon Catheter Market FDA Recalls74
4.3.3 Interventional Coronary Catheter Market FDA Recalls76
4.3.4 Interventional Coronary Guidewire Market FDA Recalls79
4.3.5 Coronary Atherectomy and Intravascular Lithotripsy Device Market FDA Recalls80
4.3.6 Coronary Introducer Sheath Market FDA Recalls81
4.3.7 Coronary Vascular Closure Device Market FDA Recalls85
4.3.8 Diagnostic Coronary Catheter & Guidewire Market FDA Recalls86
4.3.9 Coronary Intravascular Ultrasound Market FDA Recalls87
4.4 Clinical Trials88
4.4.1 Coronary Stent Market Clinical Trials89
4.4.2 Coronary Balloon Catheter Market Clinical Trials95
4.4.3 Interventional Coronary Catheter Market Clinical Trials99
4.4.4 Interventional Coronary Guidewire Market Clinical Trials101
4.4.5 Coronary Embolic Protection Device Market Clinical Trials102
4.4.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market Clinical Trials104
4.4.7 Coronary Vascular Closure Device106
4.4.8 Coronary Intravascular Ultrasound112
4.4.9 Coronary Optical Coherence Tomography116
Global Interventional cardiology Device Market Overview118
5.1 Introduction118
5.1.1 Population at Risk118
5.2 Market Overview & Trend Analysis120
5.2.1 By Segment120
5.2.2 By Region126
5.3 Drivers and Limiters130
5.3.1 Market Drivers130
5.3.2 Market Limiters132
5.4 Competitive Market Share Analysis134
5.5 Mergers and Acquisitions142
5.6 Company Profiles144
5.6.1 Abbott144
5.6.2 Asahi Intecc145
5.6.3 Boston Scientific146
5.6.4 Cook Medical147
5.6.5 Cordis148
5.6.6 Medtronic149
5.6.7 Penumbra150
5.6.8 Philips151
5.6.9 Teleflex152
5.6.10 Terumo153
5.7 SWOT Analysis154
5.7.1 Abbott155
5.7.2 Asahi Intecc157
5.7.3 Boston Scientific158
5.7.4 Cordis159
5.7.5 Cook Medical160
5.7.6 Medtronic161
5.7.7 Penumbra162
5.7.8 Philips163
5.7.9 Teleflex164
5.7.10 Terumo165
Coronary Stent Market166
6.1 Executive Summary166
6.1.1 Global Coronary Stent Market Overview166
6.1.2 Competitive Analysis168
6.1.3 Procedures Included169
6.1.4 Markets Included170
6.1.5 Regions Included171
6.2 Introduction173
6.3 Procedure Numbers175
6.4 Market Overview189
6.4.1 By Segment190
6.4.2 By Region192
6.5 Market Analysis and Forecast194
6.5.1 Total Coronary Stent Market194
6.5.2 Bare-Metal Stent Market198
6.5.3 Drug-Eluting Stent Market202
6.6 Drivers and Limiters206
6.6.1 Market Drivers206
6.6.2 Market Limiters207
6.7 Competitive Market Share Analysis209
Coronary Balloon Catheter Market213
7.1 Executive Summary213
7.1.1 Global Coronary Balloon Catheter Market Overview213
7.1.2 Competitive Analysis216
7.1.3 Procedures Included217
7.1.4 Markets Included218
7.1.5 Regions Included219
7.2 Introduction221
7.3 Procedure Numbers223
7.4 Market Overview237
7.4.1 By Segment238
7.4.2 By Region240
7.5 Market Analysis and Forecast242
7.5.1 Total Coronary Balloon Catheter Market242
7.5.2 PTCA Balloon Catheter Market246
7.5.3 Specialty Balloon Catheter Market250
7.6 Drivers and Limiters254
7.6.1 Market Drivers254
7.6.2 Market Limiters254
7.7 Competitive Market Share Analysis256
interventional coronary catheter Market260
8.1 Executive Summary260
8.1.1 Global Interventional Coronary Catheter Market Overview260
8.1.2 Competitive Analysis262
8.1.3 Procedures Included263
8.1.4 Regions Included264
8.2 Introduction266
8.3 Procedure Numbers267
8.4 Market Analysis and Forecast281
8.5 Drivers and Limiters285
8.5.1 Market Drivers285
8.5.2 Market Limiters285
8.6 Competitive Market Share Analysis287
Interventional Coronary guidewire Market291
9.1 Executive Summary291
9.1.1 Global Interventional Coronary Guidewire Market Overview291
9.1.2 Competitive Analysis293
9.1.3 Procedures Included294
9.1.4 Regions Included295
9.2 Introduction297
9.3 Procedure Numbers298
9.4 Market Analysis and Forecast312
9.5 Drivers and Limiters316
9.5.1 Market Drivers316
9.5.2 Market Limiters317
9.6 Competitive Market Share Analysis318
Coronary embolic protection device Market322
10.1 Executive Summary322
10.1.1 Global Coronary Embolic Protection Device Market Overview322
10.1.2 Competitive Analysis325
10.1.3 Regions Included326
10.2 Introduction328
10.2.1 Protection Mechanism328
10.2.1.1 Filter Basket328
10.2.1.2 Distal Balloon Occlusion328
10.3 Market Analysis and Forecast330
10.4 Drivers and Limiters334
10.4.1 Market Drivers334
10.4.2 Market Limiters335
10.5 Competitive Market Share Analysis336
Atherectomy and Intravascular Lithotripsy Device Market339
11.1 Executive Summary339
11.1.1 Global Atherectomy and Intravascular Lithotripsy Device Market Overview339
11.1.2 Competitive Analysis342
11.1.3 Procedures Included343
11.1.4 Regions Included344
11.2 Introduction346
11.3 Procedure Numbers347
11.4 Market Analysis and Forecast361
11.5 Drivers and Limiters365
11.5.1 Market Drivers365
11.5.2 Market Limiters366
11.6 Competitive Market Share Analysis367
Coronary Introducer Sheath Market370
12.1 Executive Summary370
12.1.1 Global Coronary Introducer Sheath Market Overview370
12.1.2 Competitive Analysis373
12.1.3 Procedures Included374
12.1.4 Regions Included375
12.2 Introduction377
12.2.1 Introducer Sheaths377
12.2.2 Micro-Introducers377
12.2.3 Catheter Insertion Approaches378
12.2.3.1 Femoral Approach378
12.2.3.2 Radial/Brachial Approach378
12.3 Procedure Numbers379
12.4 Market Analysis and Forecast393
12.5 Drivers and Limiters397
12.5.1 Market Drivers397
12.5.2 Market Limiters397
12.6 Competitive Market Share Analysis399
Coronary Vascular Closure Device Market404
13.1 Executive Summary404
13.1.1 Global Coronary Vascular Closure Device Market Overview404
13.1.2 Competitive Analysis406
13.1.3 Procedures Included407
13.1.4 Markets Included408
13.1.5 Regions Included409
13.2 Introduction411
13.2.1 Intravascular and Extravascular Devices411
13.3 Procedure Numbers412
13.4 Market Overview426
13.4.1 By Segment427
13.4.2 By Region429
13.5 Market Analysis and Forecast431
13.5.1 Total Coronary Vascular Closure Device Market431
13.5.2 Invasive VCD Market436
13.5.3 Non-Invasive VCD Market440
13.6 Drivers and Limiters444
13.6.1 Market Drivers444
13.6.2 Market Limiters445
13.7 Competitive Market Share Analysis446
Diagnostic Catheter and Guidewire Market450
14.1 Executive Summary450
14.1.1 Global Diagnostic Catheter and Guidewire Market Overview450
14.1.2 Competitive Analysis453
14.1.3 Procedures Included454
14.1.4 Markets Included455
14.1.5 Regions Included456
14.2 Introduction458
14.3 Procedure Numbers459
14.3.1 Total Procedures459
14.3.2 Angiography Procedures460
14.3.3 FFR Guidewire Procedures474
14.4 Market Overview488
14.4.1 By Segment489
14.4.2 By Region491
14.5 Market Analysis and Forecast493
14.5.1 Total Diagnostic Catheter and Guidewire Market493
14.5.2 Interventional Diagnostic Catheter Market497
14.5.3 Interventional Diagnostic Guidewire Market501
14.5.4 FFR Guidewire Market505
14.6 Drivers and Limiters509
14.6.1 Market Drivers509
14.6.2 Market Limiters509
14.7 Competitive Market Share Analysis511
Optical Coherence Tomography Catheter Market516
15.1 Executive Summary516
15.1.1 Global Optical Coherence Tomography Catheter Market Overview516
15.1.2 Competitive Analysis518
15.1.3 Procedures Included519
15.1.4 Regions Included520
15.2 Introduction522
15.2.1 OCT Applications523
15.3 Procedure Numbers524
15.4 Market Analysis and Forecast538
15.5 Drivers and Limiters542
15.5.1 Market Drivers542
15.5.2 Market Limiters543
15.6 Competitive Market Share Analysis544
Intravascular Ultrasound Catheter Market547
16.1 Executive Summary547
16.1.1 Global Intravascular Ultrasound Catheter Market Overview547
16.1.2 Competitive Analysis549
16.1.3 Procedures Included550
16.1.4 Regions Included551
16.2 Introduction553
16.2.1 Pre-Stenting Applications553
16.2.2 Post-Stenting Applications553
16.3 Procedure Numbers554
16.4 Market Analysis and Forecast568
16.5 Drivers and Limiters572
16.5.1 Market Drivers572
16.5.2 Market Limiters573
16.6 Competitive Market Share Analysis574
Abbreviations577
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite includes analysis on the following companies currently active in this market:
 Abbott Kardia
 Acrostak Kimal
 Advanced Vascular Dynamics Kojima Medical
 Alvimedica Kossel Medical
 AndraTec Lepu
 AngioDynamics MedAlliance
 Argon Medical Medinol
 Asahi Intecc Medtronic
 Avinger Meril Life Sciences
 B. Braun Merit Medical
 Balton Medical Morris Innovative
 Barty Medical Nipro
 Baylis Medical Opsens Medical
 Becton Dickinson OrbusNeich
 Biolife Oscor
 Biosensors PediaVascular
 Biotronik Philips
 Bolton Medical Reflow Medical
 Boston Scientific Rontis
 Cardionovum SCW Medicath
 Cardiovascular Systems, Inc. Semler Technologies
 Cardiva Medical Shenzhen MicroApproach Medical Technology
 CeloNova BioSciences Shenzhen X-Way Medical Technology
 Conavi ShockWave Medical
 Contego Medical SMT
 Cook Medical Stentys
 Cordis Teleflex
 DISA Medinotec Terumo
 Elixir Medical Corporation Tricol Biomedical
 Eucatech KAI Medical
 Galt Medical TZ Medical
 Hexacath Vascular Perspectives
 IMDS Vasorum
 InnoTherapy WEGO
 Innovative Cardiovascular Solutions LLC Wellinq
 iVascular Z-Medica
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Chart List:
List of Charts
Chart 1‑1: Interventional Cardiology Market by Segment, Global, 2022 – 20292
Chart 1‑2: Interventional Cardiology Procedures, Global, 2022 & 20292
Chart 2‑1: Multi-Scenario Interventional Cardiology Market Forecast, Global, 2019 – 2029 (US$M)40
Chart 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029125
Chart 5‑2: Interventional Cardiology Market by Region, Global, 2019 – 2029129
Chart 5‑3: Leading Competitors, Interventional Cardiology Market, Global, 2022141
Chart 6‑1: Coronary Stent Market, Global, 2022 & 2029167
Chart 6‑2: Angioplasty/PCI Procedures, Global, 2022167
Chart 6‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029177
Chart 6‑4: Coronary Stent Market by Segment, Global, 2019 – 2022191
Chart 6‑5: Coronary Stent Market by Region, Global, 2019 – 2029193
Chart 6‑6: Leading Competitors, Coronary Stent Market, Global, 2022212
Chart 7‑1: Coronary Balloon Catheter Market, Global, 2022 & 2029215
Chart 7‑2: Angioplasty/PCI Procedures, Global, 2022215
Chart 7‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029225
Chart 7‑4: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029239
Chart 7‑5: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029241
Chart 7‑6: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022259
Chart 8‑1: Interventional Coronary Catheter Market, Global, 2022 & 2029261
Chart 8‑2: Angioplasty/PCI Procedures, Global, 2022261
Chart 8‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029269
Chart 8‑4: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022290
Chart 9‑1: Interventional Coronary Guidewire Market, Global, 2022 & 2029292
Chart 9‑2: Angioplasty/PCI Procedures, Global, 2022292
Chart 9‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029300
Chart 9‑4: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022321
Chart 10‑1: Coronary Embolic Protection Device Market, Global, 2022 & 2029324
Chart 10‑2: Coronary Embolic Protection Procedures, Global, 2022324
Chart 10‑3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022338
Chart 11‑1: Atherectomy and IVL Device Market, Global, 2022 & 2029341
Chart 11‑2: Atherectomy and IVL Procedures, Global, 2022341
Chart 11‑3: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029349
Chart 11‑4: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022369
Chart 12‑1: Coronary Introducer Sheath Market, Global, 2022 & 2029372
Chart 12‑2: Coronary Introducer Sheath Procedures, Global, 2022372
Chart 12‑3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029381
Chart 12‑4: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022403
Chart 13‑1: Coronary Vascular Closure Device Market, Global, 2022 & 2029405
Chart 13‑2: Coronary Vascular Closure Device Procedures, Global, 2022405
Chart 13‑3: Catheterization Procedures by Region, Global, 2019 – 2029414
Chart 13‑4: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029428
Chart 13‑5: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029430
Chart 13‑6: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022449
Chart 14‑1: Diagnostic Catheter and Guidewire Market, Global, 2022 & 2029452
Chart 14‑2: Diagnostic Catheter and Guidewire Procedures, Global, 2022452
Chart 14‑3: Angiography Procedures by Region, Global, 2019 – 2029462
Chart 14‑4: FFR Guidewire Procedures by Region, Global, 2019 – 2029476
Chart 14‑5: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029490
Chart 14‑6: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029492
Chart 14‑7: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022515
Chart 15‑1: OCT Catheter Market, Global, 2022 & 2029517
Chart 15‑2: OCT Catheter Procedures, Global, 2022517
Chart 15‑3: OCT Procedures by Region, Global, 2019 – 2029526
Chart 15‑4: Leading Competitors, OCT Catheter Market, Global, 2022546
Chart 16‑1: IVUS Catheter Market, Global, 2022 & 2029548
Chart 16‑2: IVUS Catheter Procedures, Global, 2022548
Chart 16‑3: IVUS Procedures by Region, Global, 2019 – 2029556
Chart 16‑4: Leading Competitors, IVUS Catheter Market, Global, 2022576
The Interventional Cardiology Market Report Suite| Global | 2023-2029 | MedSuite Figure List:
List of Figures
Figure 1‑1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2)4
Figure 1‑2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2)4
Figure 1‑3: Companies Researched in This Report (1 of 2)5
Figure 1‑4: Companies Researched in This Report (2 of 2)6
Figure 1‑5: Factors Impacting the Interventional Cardiology Device Market by Segment,  Global (1 of 2)7
Figure 1‑6: Factors Impacting the Interventional Cardiology Device Market by Segment,  Global (2 of 2)8
Figure 1‑7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2)9
Figure 1‑8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2)10
Figure 1‑9: Interventional Cardiology Device Procedures Covered11
Figure 1‑10: Interventional Cardiology Device Markets Covered12
Figure 1‑11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2)13
Figure 1‑12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2)14
Figure 1‑13: Version History15
Figure 2‑1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)34
Figure 2‑2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)35
Figure 2‑3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)36
Figure 2‑4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)37
Figure 2‑5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)38
Figure 2‑6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)39
Figure 4‑1: Coronary Stents by Company50
Figure 4‑2: Coronary Balloon Catheters by Company52
Figure 4‑3: Interventional Coronary Catheters by Company54
Figure 4‑4: Interventional Coronary Guidewires by Company56
Figure 4‑5: Coronary Embolic Protection Devices by Company58
Figure 4‑6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company60
Figure 4‑7: Coronary Introducer Sheaths by Company (1 of 2)62
Figure 4‑8: Coronary Introducer Sheaths by Company (2 of 2)63
Figure 4‑9: Coronary Vascular Closure Devices by Company65
Figure 4‑10: Diagnostic Coronary Catheters & Guidewires by Company67
Figure 4‑11: Coronary Intravascular Ultrasound Devices by Company69
Figure 4‑12: Coronary Optical Coherence Tomography by Company71
Figure 4‑13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System72
Figure 4‑14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm72
Figure 4‑15: Class 2 Device Recall Cordis Precise Nitinol Stent System72
Figure 4‑16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System73
Figure 4‑17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System73
Figure 4‑18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter74
Figure 4‑19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter74
Figure 4‑20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters75
Figure 4‑21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter75
Figure 4‑22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter75
Figure 4‑23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter75
Figure 4‑24: Class 2 Device Recall MAMBA Flex 135 Microcatheter76
Figure 4‑25: Class 2 Device Recall MAMBA Microcatheter76
Figure 4‑26: Class 2 Device Recall Guidezilla II Guide Extension Catheter76
Figure 4‑27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER77
Figure 4‑28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter77
Figure 4‑29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters77
Figure 4‑30: Class 1 Device Recall 6F Taiga Guiding Catheter78
Figure 4‑31: Class 2 Device Recall Destination Guiding Sheath78
Figure 4‑32: Class 2 Device Recall Stingray" Guidewire79
Figure 4‑33: Class 1 Device Recall TurboHawk Plus80
Figure 4‑34: Class 1 Device Recall HawkOne80
Figure 4‑35: Class 2 Device Recall Boston Scientific ROTAPRO80
Figure 4‑36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM80
Figure 4‑37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER81
Figure 4‑38: Class 2 Device Recall81
Figure 4‑39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification81
Figure 4‑40: Class 2 Device Recall Prelude Short Sheath Introducer82
Figure 4‑41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer82
Figure 4‑42: Class 2 Device Recall Avanti Catheter Sheath Introducer82
Figure 4‑43: Class 1 Device Recall Flexor CheckFlo Introducer82
Figure 4‑44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS83
Figure 4‑45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER83
Figure 4‑46: Class 1 Device Recall Portico Solo ReCollapsible Access System83
Figure 4‑47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System83
Figure 4‑48: Class 2 Device Recall Microintroducer Kit84
Figure 4‑49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices85
Figure 4‑50: Class 2 Device Recall AngioSeal Evolution85
Figure 4‑51: Class 1 Device Recall Imager II 5F Angiographic Catheter86
Figure 4‑52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter87
Figure 4‑53: Class 2 Device Recall iLab Polaris MultiModality Guidance System87
Figure 4‑54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN)89
Figure 4‑55: RESOLUTE ONYX China Single Arm Study89
Figure 4‑56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)90
Figure 4‑57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System90
Figure 4‑58: PROMUS PREMIER™ China Post-Approval Study91
Figure 4‑59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)91
Figure 4‑60: China Resolute Integrity 34/38 mm Study92
Figure 4‑61: ILUMIEN IV: OPTIMAL PCI92
Figure 4‑62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)93
Figure 4‑63: RESOLUTE ONYX Post-Approval Study (ONYX PAS)93
Figure 4‑64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V)94
Figure 4‑65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)94
Figure 4‑66: Sirolimus DEB in Coronary Bifurcation Lesions95
Figure 4‑67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)95
Figure 4‑68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)96
Figure 4‑69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST)96
Figure 4‑70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater97
Figure 4‑71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I)97
Figure 4‑72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease97
Figure 4‑73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases98
Figure 4‑74: FIRE AND ICE II Trial Pilot99
Figure 4‑75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD)99
Figure 4‑76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First)100
Figure 4‑77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI)101
Figure 4‑78: Pressure Guidewire Comparison101
Figure 4‑79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2)102
Figure 4‑80: transShield Embolic Protection System Feasibility Study102
Figure 4‑81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation103
Figure 4‑82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis103
Figure 4‑83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s104
Figure 4‑84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT)104
Figure 4‑85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT)105
Figure 4‑86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD)105
Figure 4‑87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial106
Figure 4‑88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF)106
Figure 4‑89: Application of Vascular Closure Device in Transvenous Cardiac Intervention107
Figure 4‑90: Comparison of Different Vascular Closure Device in TAVI107
Figure 4‑91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease108
Figure 4‑92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE)108
Figure 4‑93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial109
Figure 4‑94: Vascular Closure Device in Transcatheter Aortic Valve Replacement109
Figure 4‑95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)110
Figure 4‑96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)110
Figure 4‑97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System111
Figure 4‑98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)111
Figure 4‑99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER)112
Figure 4‑100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS)112
Figure 4‑101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP)113
Figure 4‑102: The OPTIMAL Randomized Controlled Trial113
Figure 4‑103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite)114
Figure 4‑104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES)114
Figure 4‑105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS)115
Figure 4‑106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB)116
Figure 4‑107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography116
Figure 4‑108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM)117
Figure 4‑109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging117
Figure 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2)123
Figure 5‑2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2)124
Figure 5‑3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M)128
Figure 5‑4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2)139
Figure 5‑5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2)140
Figure 5‑6: SWOT Analysis, Abbott (1 of 2)155
Figure 5‑7: SWOT Analysis, Abbott (2 of 2)156
Figure 5‑8: SWOT Analysis, Asahi Intecc157
Figure 5‑9: SWOT Analysis, Boston Scientific158
Figure 5‑10: SWOT Analysis, Cordis159
Figure 5‑11: SWOT Analysis, Cook Medical160
Figure 5‑12: SWOT Analysis, Medtronic161
Figure 5‑13: SWOT Analysis, Penumbra162
Figure 5‑14: SWOT Analysis, Philips163
Figure 5‑15: SWOT Analysis, Teleflex164
Figure 5‑16: SWOT Analysis, Terumo165
Figure 6‑1: Coronary Stent Procedures Covered169
Figure 6‑2: Coronary Stent Markets Covered170
Figure 6‑3: Coronary Stent Regions Covered, Global (1 of 2)171
Figure 6‑4: Coronary Stent Regions Covered, Global (2 of 2)172
Figure 6‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029176
Figure 6‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029178
Figure 6‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)179
Figure 6‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)180
Figure 6‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029181
Figure 6‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)182
Figure 6‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)183
Figure 6‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029184
Figure 6‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)185
Figure 6‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)186
Figure 6‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)187
Figure 6‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029188
Figure 6‑17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M)190
Figure 6‑18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M)192
Figure 6‑19: Total Coronary Stent Market, Global, 2019 – 2029194
Figure 6‑20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029195
Figure 6‑21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$)196
Figure 6‑22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M)197
Figure 6‑23: Bare-Metal Stent Market, Global, 2019 – 2029198
Figure 6‑24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029199
Figure 6‑25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$)200
Figure 6‑26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M)201
Figure 6‑27: Drug-Eluting Stent Market, Global, 2019 – 2029202
Figure 6‑28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029203
Figure 6‑29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$)204
Figure 6‑30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M)205
Figure 6‑31: Leading Competitors, Coronary Stent Market, Global, 2022211
Figure 7‑1: Coronary Balloon Catheter Procedures Covered217
Figure 7‑2: Coronary Balloon Catheter Markets Covered218
Figure 7‑3: Coronary Balloon Catheter Regions Covered, Global (1 of 2)219
Figure 7‑4: Coronary Balloon Catheter Regions Covered, Global (2 of 2)220
Figure 7‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029224
Figure 7‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029226
Figure 7‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)227
Figure 7‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)228
Figure 7‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029229
Figure 7‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)230
Figure 7‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)231
Figure 7‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029232
Figure 7‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)233
Figure 7‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)234
Figure 7‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)235
Figure 7‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029236
Figure 7‑17: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 (US$M)238
Figure 7‑18: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 (US$M)240
Figure 7‑19: Total Coronary Balloon Catheter Market, Global, 2019 – 2029242
Figure 7‑20: Units Sold by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029243
Figure 7‑21: Average Selling Price by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$)244
Figure 7‑22: Market Value by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$M)245
Figure 7‑23: PTCA Balloon Catheter Market, Global, 2019 – 2029246
Figure 7‑24: Units Sold by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029247
Figure 7‑25: Average Selling Price by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$)248
Figure 7‑26: Market Value by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$M)249
Figure 7‑27: Specialty Balloon Catheter Market, Global, 2019 – 2029250
Figure 7‑28: Units Sold by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029251
Figure 7‑29: Average Selling Price by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$)252
Figure 7‑30: Market Value by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$M)253
Figure 7‑31: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022258
Figure 8‑1: Interventional Coronary Catheter Procedures Covered263
Figure 8‑2: Interventional Coronary Catheter Regions Covered, Global (1 of 2)264
Figure 8‑3: Interventional Coronary Catheter Regions Covered, Global (2 of 2)265
Figure 8‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029268
Figure 8‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029270
Figure 8‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)271
Figure 8‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)272
Figure 8‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029273
Figure 8‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)274
Figure 8‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)275
Figure 8‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029276
Figure 8‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)277
Figure 8‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)278
Figure 8‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)279
Figure 8‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029280
Figure 8‑16: Interventional Coronary Catheter Market, Global, 2019 – 2029281
Figure 8‑17: Units Sold by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029282
Figure 8‑18: Average Selling Price by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$)283
Figure 8‑19: Market Value by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$M)284
Figure 8‑20: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022289
Figure 9‑1: Interventional Coronary Guidewire Procedures Covered294
Figure 9‑2: Interventional Coronary Guidewire Regions Covered, Global (1 of 2)295
Figure 9‑3: Interventional Coronary Guidewire Regions Covered, Global (2 of 2)296
Figure 9‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029299
Figure 9‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029301
Figure 9‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)302
Figure 9‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)303
Figure 9‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029304
Figure 9‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)305
Figure 9‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)306
Figure 9‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029307
Figure 9‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)308
Figure 9‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)309
Figure 9‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)310
Figure 9‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029311
Figure 9‑16: Interventional Coronary Guidewire Market, Global, 2019 – 2029312
Figure 9‑17: Units Sold by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029313
Figure 9‑18: Average Selling Price by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$)314
Figure 9‑19: Market Value by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$M)315
Figure 9‑20: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022320
Figure 10‑1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2)326
Figure 10‑2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2)327
Figure 10‑3: Coronary Embolic Protection Device Market, Global, 2019 – 2029330
Figure 10‑4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029331
Figure 10‑5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$)332
Figure 10‑6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$M)333
Figure 10‑7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022337
Figure 11‑1: Atherectomy and IVL Device Procedures Covered343
Figure 11‑2: Atherectomy and IVL Device Regions Covered, Global (1 of 2)344
Figure 11‑3: Atherectomy and IVL Device Regions Covered, Global (2 of 2)345
Figure 11‑4: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029348
Figure 11‑5: Coronary Atherectomy and IVL Procedures by Country, North America, 2019 – 2029350
Figure 11‑6: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (1 of 2)351
Figure 11‑7: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (2 of 2)352
Figure 11‑8: Coronary Atherectomy and IVL Procedures by Country, Western Europe, 2019 – 2029353
Figure 11‑9: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)354
Figure 11‑10: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)355
Figure 11‑11: Coronary Atherectomy and IVL Procedures by Country, Middle East, 2019 – 2029356
Figure 11‑12: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)357
Figure 11‑13: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)358
Figure 11‑14: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)359
Figure 11‑15: Coronary Atherectomy and IVL Procedures by Country, Africa, 2019 – 2029360
Figure 11‑16: Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029361
Figure 11‑17: Units Sold by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029362
Figure 11‑18: Average Selling Price by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$)363
Figure 11‑19: Market Value by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$M)364
Figure 11‑20: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022368
Figure 12‑1: Coronary Introducer Sheath Procedures Covered374
Figure 12‑2: Coronary Introducer Sheath Regions Covered, Global (1 of 2)375
Figure 12‑3: Coronary Introducer Sheath Regions Covered, Global (2 of 2)376
Figure 12‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029380
Figure 12‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029382
Figure 12‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)383
Figure 12‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)384
Figure 12‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029385
Figure 12‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)386
Figure 12‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)387
Figure 12‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029388
Figure 12‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)389
Figure 12‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)390
Figure 12‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)391
Figure 12‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029392
Figure 12‑16: Coronary Introducer Sheath Market, Global, 2019 – 2029393
Figure 12‑17: Units Sold by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029394
Figure 12‑18: Average Selling Price by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$)395
Figure 12‑19: Market Value by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$M)396
Figure 12‑20: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022402
Figure 13‑1: Coronary Vascular Closure Device Procedures Covered407
Figure 13‑2: Coronary Vascular Closure Device Markets Covered408
Figure 13‑3: Coronary Vascular Closure Device Regions Covered, Global (1 of 2)409
Figure 13‑4: Coronary Vascular Closure Device Regions Covered, Global (2 of 2)410
Figure 13‑5: Total Catheterization Procedures by Region, Global, 2019 – 2029413
Figure 13‑6: Catheterization Procedures by Country, North America, 2019 – 2029415
Figure 13‑7: Catheterization Procedures by Country, Latin America, 2019 – 2029 (1 of 2)416
Figure 13‑8: Catheterization Procedures by Country, Latin America, 2019 – 2029 (2 of 2)417
Figure 13‑9: Catheterization Procedures by Country, Western Europe, 2019 – 2029418
Figure 13‑10: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)419
Figure 13‑11: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)420
Figure 13‑12: Catheterization Procedures by Country, Middle East, 2019 – 2029421
Figure 13‑13: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)422
Figure 13‑14: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)423
Figure 13‑15: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)424
Figure 13‑16: Catheterization Procedures by Country, Africa, 2019 – 2029425
Figure 13‑17: Coronary Vascular Closure Device Market by Segment,  Global, 2019 – 2029 (US$M)427
Figure 13‑18: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 (US$M)429
Figure 13‑19: Coronary Vascular Closure Device Market, Global, 2019 – 2029432
Figure 13‑20: Units Sold by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029433
Figure 13‑21: Average Selling Price by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$)434
Figure 13‑22: Market Value by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$M)435
Figure 13‑23: Invasive VCD Market, Global, 2019 – 2029436
Figure 13‑24: Units Sold by Region, Invasive VCD Market, Global, 2019 – 2029437
Figure 13‑25: Average Selling Price by Region, Invasive VCD Market, Global, 2019 – 2029 (US$)438
Figure 13‑26: Market Value by Region, Invasive VCD Market, Global, 2019 – 2029 (US$M)439
Figure 13‑27: Non-Invasive VCD Market, Global, 2019 – 2029440
Figure 13‑28: Units Sold by Region, Non-Invasive VCD Market, Global, 2019 – 2029441
Figure 13‑29: Average Selling Price by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$)442
Figure 13‑30: Market Value by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$M)443
Figure 13‑31: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022448
Figure 14‑1: Diagnostic Catheter and Guidewire Procedures Covered454
Figure 14‑2: Diagnostic Catheter and Guidewire Markets Covered455
Figure 14‑3: Diagnostic Catheter and Guidewire Regions Covered, Global (1 of 2)456
Figure 14‑4: Diagnostic Catheter and Guidewire Regions Covered, Global (2 of 2)457
Figure 14‑5: Total Diagnostic Catheter and Guidewire Procedures by Segment,  Global, 2019 – 2029459
Figure 14‑6: Angiography Procedures by Region, Global, 2019 – 2029461
Figure 14‑7: Angiography Procedures by Country, North America, 2019 – 2029463
Figure 14‑8: Angiography Procedures by Country, Latin America, 2019 – 2029 (1 of 2)464
Figure 14‑9: Angiography Procedures by Country, Latin America, 2019 – 2029 (2 of 2)465
Figure 14‑10: Angiography Procedures by Country, Western Europe, 2019 – 2029466
Figure 14‑11: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)467
Figure 14‑12: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)468
Figure 14‑13: Angiography Procedures by Country, Middle East, 2019 – 2029469
Figure 14‑14: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)470
Figure 14‑15: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)471
Figure 14‑16: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)472
Figure 14‑17: Angiography Procedures by Country, Africa, 2019 – 2029473
Figure 14‑18: FFR Guidewire Procedures by Region, Global, 2019 – 2029475
Figure 14‑19: FFR Guidewire Procedures by Country, North America, 2019 – 2029477
Figure 14‑20: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (1 of 2)478
Figure 14‑21: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (2 of 2)479
Figure 14‑22: FFR Guidewire Procedures by Country, Western Europe, 2019 – 2029480
Figure 14‑23: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)481
Figure 14‑24: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)482
Figure 14‑25: FFR Guidewire Procedures by Country, Middle East, 2019 – 2029483
Figure 14‑26: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)484
Figure 14‑27 FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)485
Figure 14‑28: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)486
Figure 14‑29: FFR Guidewire Procedures by Country, Africa, 2019 – 2029487
Figure 14‑30: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 (US$M)489
Figure 14‑31: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 (US$M)491
Figure 14‑32: Total Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029493
Figure 14‑33: Units Sold by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029494
Figure 14‑34: Average Selling Price by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$)495
Figure 14‑35: Market Value by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$M)496
Figure 14‑36: Interventional Diagnostic Catheter Market, Global, 2019 – 2029497
Figure 14‑37: Units Sold by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029498
Figure 14‑38: Average Selling Price by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$)499
Figure 14‑39: Market Value by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$M)500
Figure 14‑40: Interventional Diagnostic Guidewire Market, Global, 2019 – 2029501
Figure 14‑41: Units Sold by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029502
Figure 14‑42: Average Selling Price by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$)503
Figure 14‑43: Market Value by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$M)504
Figure 14‑44: FFR Guidewire Market, Global, 2019 – 2029505
Figure 14‑45: Units Sold by Region, FFR Guidewire Market, Global, 2019 – 2029506
Figure 14‑46: Average Selling Price by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$)507
Figure 14‑47: Market Value by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$M)508
Figure 14‑48: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022514
Figure 15‑1: OCT Catheter Procedures Covered519
Figure 15‑2: OCT Catheter Regions Covered, Global (1 of 2)520
Figure 15‑3: OCT Catheter Regions Covered, Global (2 of 2)521
Figure 15‑4: OCT Procedures by Region, Global, 2019 – 2029525
Figure 15‑5: OCT Procedures by Country, North America, 2019 – 2029527
Figure 15‑6: OCT Procedures by Country, Latin America, 2019 – 2029 (1 of 2)528
Figure 15‑7: OCT Procedures by Country, Latin America, 2019 – 2029 (2 of 2)529
Figure 15‑8: OCT Procedures by Country, Western Europe, 2019 – 2029530
Figure 15‑9: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)531
Figure 15‑10: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)532
Figure 15‑11: OCT Procedures by Country, Middle East, 2019 – 2029533
Figure 15‑12: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)534
Figure 15‑13: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)535
Figure 15‑14: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)536
Figure 15‑15: OCT Procedures by Country, Africa, 2019 – 2029537
Figure 15‑16: OCT Catheter Market, Global, 2019 – 2029538
Figure 15‑17: Units Sold by Region, OCT Catheter Market, Global, 2019 – 2029539
Figure 15‑18: Average Selling Price by Region, OCT Catheter Market, Global, 2019 – 2029 (US$)540
Figure 15‑19: Market Value by Region, OCT Catheter Market, Global, 2019 – 2029 (US$M)541
Figure 15‑20: Leading Competitors, OCT Catheter Market, Global, 2022545
Figure 16‑1: IVUS Catheter Procedures Covered550
Figure 16‑2: IVUS Catheter Regions Covered, Global (1 of 2)551
Figure 16‑3: IVUS Catheter Regions Covered, Global (2 of 2)552
Figure 16‑4: IVUS Procedures by Region, Global, 2019 – 2029555
Figure 16‑5: IVUS Procedures by Country, North America, 2019 – 2029557
Figure 16‑6: IVUS Procedures by Country, Latin America, 2019 – 2029 (1 of 2)558
Figure 16‑7: IVUS Procedures by Country, Latin America, 2019 – 2029 (2 of 2)559
Figure 16‑8: IVUS Procedures by Country, Western Europe, 2019 – 2029560
Figure 16‑9: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)561
Figure 16‑10: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)562
Figure 16‑11: IVUS Procedures by Country, Middle East, 2019 – 2029563
Figure 16‑12: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)564
Figure 16‑13: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)565
Figure 16‑14: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)566
Figure 16‑15: IVUS Procedures by Country, Africa, 2019 – 2029567
Figure 16‑16: IVUS Catheter Market, Global, 2019 – 2029568
Figure 16‑17: Units Sold by Region, IVUS Catheter Market, Global, 2019 – 2029569
Figure 16‑18: Average Selling Price by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$)570
Figure 16‑19: Market Value by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$M)571
Figure 16‑20: Leading Competitors, IVUS Catheter Market, Global, 2022575

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

iData’s global interventional cardiology MedSuite covers 11 markets including the coronary stent and introducer sheath markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

  • 2023
  • 10 Years
  • Global
  • 577
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library